These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12403367)

  • 1. Converting nonhuman primate dendritic cells into potent antigen-specific cellular immunosuppressants by genetic modification.
    Clement A; Pereboev A; Curiel DT; Dong SS; Hutchings A; Thomas JM
    Immunol Res; 2002; 26(1-3):297-302. PubMed ID: 12403367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rhesus monocyte-derived dendritic cells modified to over-express TGF-beta1 exhibit potent veto activity.
    Asiedu C; Dong SS; Pereboev A; Wang W; Navarro J; Curiel DT; Thomas JM
    Transplantation; 2002 Sep; 74(5):629-37. PubMed ID: 12352878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoregulatory role of CD8alpha in the veto effect.
    Asiedu C; Meng Y; Wang W; Huang Z; Contreras JL; George JF; Thomas JM
    Transplantation; 1999 Feb; 67(3):372-80. PubMed ID: 10030281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for transforming growth factor-beta in the veto mechanism in transplant tolerance.
    Verbanac KM; Carver FM; Haisch CE; Thomas JM
    Transplantation; 1994 Mar; 57(6):893-900. PubMed ID: 8154038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further studies of veto activity in rhesus monkey bone marrow in relation to allograft tolerance and chimerism.
    Thomas JM; Carver FM; Kasten-Jolly J; Haisch CE; Rebellato LM; Gross U; Vore SJ; Thomas FT
    Transplantation; 1994 Jan; 57(1):101-15. PubMed ID: 8291095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor β1 and Fas ligand synergistically enhance immune tolerance in dendritic cells in liver transplantation.
    Qiu M; Chen Y; Chen L; Zeng J; Liu J
    J Surg Res; 2017 Oct; 218():180-193. PubMed ID: 28985848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retroviral delivery of transforming growth factor-beta1 to myeloid dendritic cells: inhibition of T-cell priming ability and influence on allograft survival.
    Takayama T; Kaneko K; Morelli AE; Li W; Tahara H; Thomson AW
    Transplantation; 2002 Jul; 74(1):112-9. PubMed ID: 12134108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of CD40 pathway enhances the induction of immune tolerance by immature dendritic cells genetically modified to express cytotoxic T lymphocyte antigen 4 immunoglobulin.
    Sun W; Wang Q; Zhang L; Liu Y; Zhang M; Wang C; Wang J; Cao X
    Transplantation; 2003 Nov; 76(9):1351-9. PubMed ID: 14627915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kidney allograft tolerance in primates without chronic immunosuppression--the role of veto cells.
    Thomas JM; Carver FM; Cunningham PR; Olson LC; Thomas FT
    Transplantation; 1991 Jan; 51(1):198-207. PubMed ID: 1824804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival.
    Lu L; Li W; Fu F; Chambers FG; Qian S; Fung JJ; Thomson AW
    Transplantation; 1997 Dec; 64(12):1808-15. PubMed ID: 9422424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survival.
    Min WP; Gorczynski R; Huang XY; Kushida M; Kim P; Obataki M; Lei J; Suri RM; Cattral MS
    J Immunol; 2000 Jan; 164(1):161-7. PubMed ID: 10605007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
    Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
    Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-beta(1) gene modified immature dendritic cells exhibit enhanced tolerogenicity but induce allograft fibrosis in vivo.
    Sun W; Wang Q; Zhang L; Pan J; Zhang M; Lu G; Yao H; Wang J; Cao X
    J Mol Med (Berl); 2002 Aug; 80(8):514-23. PubMed ID: 12185452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotype, function, and in vivo migration and survival of allogeneic dendritic cell progenitors genetically engineered to express TGF-beta.
    Lee WC; Zhong C; Qian S; Wan Y; Gauldie J; Mi Z; Robbins PD; Thomson AW; Lu L
    Transplantation; 1998 Dec; 66(12):1810-7. PubMed ID: 9884280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastable tolerance to rhesus monkey renal transplants is correlated with allograft TGF-beta 1+CD4+ T regulatory cell infiltrates.
    Torrealba JR; Katayama M; Fechner JH; Jankowska-Gan E; Kusaka S; Xu Q; Schultz JM; Oberley TD; Hu H; Hamawy MM; Jonker M; Wubben J; Doxiadis G; Bontrop R; Burlingham WJ; Knechtle SJ
    J Immunol; 2004 May; 172(9):5753-64. PubMed ID: 15100322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of tolerance induced by transforming growth factor-beta-treated antigen-presenting cells: CD8 regulatory T cells inhibit the effector phase of the immune response in primed mice through a mechanism involving Fas ligand.
    Kosiewicz MM; Alard P; Liang S; Clark SL
    Int Immunol; 2004 May; 16(5):697-706. PubMed ID: 15096489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-β favors bone marrow-derived dendritic cells to acquire tolerogenic properties.
    Song SS; Yuan PF; Chen JY; Fu JJ; Wu HX; Lu JT; Wei W
    Immunol Invest; 2014; 43(4):360-9. PubMed ID: 24484319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrasting effects of myeloid dendritic cells transduced with an adenoviral vector encoding interleukin-10 on organ allograft and tumour rejection.
    Lee WC; Qiani S; Wan Y; Li W; Xing Z; Gauldie J; Fung JJ; Thomson AW; Lu L
    Immunology; 2000 Oct; 101(2):233-41. PubMed ID: 11012777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vivo migration and survival of donor-derived dendritic cell progenitors genetically modified using an adenoviral vector encoding cDNA for TGF beta 1].
    Zhong C; Li WZ; Lü L
    Zhonghua Yi Xue Za Zhi; 1999 Mar; 79(3):174-7. PubMed ID: 11601033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mature but not immature Fas ligand (CD95L)-transduced human monocyte-derived dendritic cells are protected from Fas-mediated apoptosis and can be used as killer APC.
    Hoves S; Krause SW; Halbritter D; Zhang HG; Mountz JD; Schölmerich J; Fleck M
    J Immunol; 2003 Jun; 170(11):5406-13. PubMed ID: 12759415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.